Cargando…

Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes

Type 2 diabetes carries a risk for hypoglycemia, particularly in patients on an intensive glucose control plan as a glucose-lowering strategy, where hypoglycemia may be a limitation for the therapy and also a factor underlying clinical inertia. Glucose-lowering medications that increase circulating...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ahrén, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639216/ https://www.ncbi.nlm.nih.gov/pubmed/23637538 http://dx.doi.org/10.2147/VHRM.S33934

Ejemplares similares

Glucose‐lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase‐4 inhibition
por: Ahrén, Bo
Publicado: (2021)

Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
por: Yun, Jae-Seung, et al.
Publicado: (2015)

Individualized targeted glucose control to avoid hypoglycemia
por: Gawel, SP, et al.
Publicado: (2013)

Restoration of the Hypothalamic-pituitary-adrenal Response to Hypoglycemia in Type 2 Diabetes by Avoiding Chronic Hypoglycemia
por: Tsuda, Shin-ichi, et al.
Publicado: (2016)

The relationship between components of hypoglycemia worries and avoiding hypoglycemia behavior in type 2 diabetes mellitus with hypoglycemia: a network analysis
por: Wu, Chao, et al.
Publicado: (2023)

Seasonal Variation in Severe Glucose-lowering Drug-induced Hypoglycemia in Patients with Type 2 Diabetes
por: Minamoto-Higashioka, Mayu, et al.
Publicado: (2019)

Estimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes
por: Ahrén, Bo, et al.
Publicado: (2016)

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
por: Ahrén, Bo
Publicado: (2010)

Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin
por: Ahrén, Bo
Publicado: (2008)

Effects of Intensive Therapy and Antecedent Hypoglycemia on Counterregulatory Responses to Hypoglycemia in Type 2 Diabetes
por: Davis, Stephen N., et al.
Publicado: (2009)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
por: Hajime, Maiko, et al.
Publicado: (2019)

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
por: Battelino, Tadej, et al.
Publicado: (2011)

Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert
por: Puhr, Sarah, et al.
Publicado: (2019)

Hypoglycemia in type 2 diabetes: Standpoint of an experts’ committee (India hypoglycemia study group)
por: Viswanathan, Mohan, et al.
Publicado: (2012)

Glucagon‐like peptide‐1 receptor agonists for type 2 diabetes: A rational drug development
por: Ahrén, Bo
Publicado: (2018)

Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?
por: Ahrén, Bo, et al.
Publicado: (2014)

Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities
por: Doucet, Jean, et al.
Publicado: (2023)

Type 1 Diabetes and Hypoglycemia
por: Bloomgarden, Zachary T.
Publicado: (2009)

Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes
por: Jabbour, Georges, et al.
Publicado: (2021)

SELF-GLUCOSE MONITORING AND HYPOGLYCEMIA RISK IN OLDER RURAL VETERANS WITH TYPE 2 DIABETES
por: Valencia, Willy Marcos, et al.
Publicado: (2019)

Glucose effectiveness: Lessons from studies on insulin‐independent glucose clearance in mice
por: Ahrén, Bo, et al.
Publicado: (2020)

Should Target Glucose Values Be Increased to Avoid Severe Hypoglycemia? Real-World Data Say “No.”
por: Welsh, John, et al.
Publicado: (2021)

Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes
por: Choudhary, Pratik, et al.
Publicado: (2013)

Hypoglycemia with gliclazide MR in women with type 2 diabetes. A continuous glucose monitoring study
por: Vianna, André G Daher, et al.
Publicado: (2015)

Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
por: Shin, Juyoung, et al.
Publicado: (2021)

Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies
por: Rooijackers, Hanne M. M., et al.
Publicado: (2015)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

The Advanced Diabetes Technologies for Reduction of the Frequency of Hypoglycemia and Minimizing the Occurrence of Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes
por: Urakami, Tatsuhiko
Publicado: (2023)

Insight into hypoglycemia in pediatric type 1 diabetes mellitus
por: Lehecka, Kimberly E, et al.
Publicado: (2012)

Safety of Antithyroid Drugs in Avoiding Hyperglycemia or Hypoglycemia in Patients With Graves’ Disease and Type 2 Diabetes Mellitus: A Literature Review
por: Hsieh, Yu-Shan
Publicado: (2023)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2020)

Lower Glucose Effectiveness Is Associated with Subclinical Reactive Hypoglycemia, Snacking Habits, and Obesity
por: Kishimoto, Ichiro, et al.
Publicado: (2023)

The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
por: Hsieh, Ming-Chia, et al.
Publicado: (2012)

Successful glucose lowering therapy triumphs in heart failure
por: Rossing, Peter
Publicado: (2021)

Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus
por: Yun, Jae-Seung, et al.
Publicado: (2016)

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia
por: Bramlage, Peter, et al.
Publicado: (2012)

The Association of Hypoglycemia Assessed by Continuous Glucose Monitoring With Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes
por: Wei, Wei, et al.
Publicado: (2019)

Type 1 Diabetes Hypoglycemia Prediction Algorithms: Systematic Review
por: Tsichlaki, Stella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1p21btbe5bn4qhu2t2k1830plr